Cognition Therapeutics Files 8-K

Ticker: CGTX · Form: 8-K · Filed: Jul 29, 2024 · CIK: 1455365

Cognition Therapeutics INC 8-K Filing Summary
FieldDetail
CompanyCognition Therapeutics INC (CGTX)
Form Type8-K
Filed DateJul 29, 2024
Risk Levellow
Pages1
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, routine-disclosure

Related Tickers: COGT

TL;DR

COGT filed an 8-K, looks like standard procedure, no major news.

AI Summary

Cognition Therapeutics, Inc. filed an 8-K on July 29, 2024, reporting other events and financial statements. The filing does not contain specific details on new material events, significant financial transactions, or executive changes, but serves as a routine update.

Why It Matters

This 8-K filing is a routine disclosure by Cognition Therapeutics, Inc. to the SEC, indicating no immediate material changes or events requiring immediate public announcement.

Risk Assessment

Risk Level: low — The filing is a routine 8-K with no disclosed material events, indicating low immediate risk from this specific filing.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Cognition Therapeutics, Inc.?

This 8-K filing serves as a Current Report for Cognition Therapeutics, Inc., reporting 'Other Events' and 'Financial Statements and Exhibits' as of July 29, 2024.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is July 29, 2024.

In which state is Cognition Therapeutics, Inc. incorporated?

Cognition Therapeutics, Inc. is incorporated in Delaware.

What is the address of Cognition Therapeutics, Inc.'s principal executive offices?

The address of Cognition Therapeutics, Inc.'s principal executive offices is 2500 Westchester Avenue Purchase, NY 10577.

Does this 8-K filing disclose any specific material events or financial updates?

Based on the provided text, this 8-K filing is categorized under 'Other Events' and 'Financial Statements and Exhibits' and does not detail specific material events or financial updates within the excerpt.

Filing Stats: 426 words · 2 min read · ~1 pages · Grade level 11.5 · Accepted 2024-07-29 08:30:25

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. Attached as Exhibit 99.1 is a presentation that the Company may use from time to time in presentations or discussions with investors, analysts, and other parties.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Document 99.1 Investor presentation of Cognition Therapeutics, Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. COGNITION THERAPEUTICS, INC. Date: July 29, 2024 By: /s/ Lisa Ricciardi Name: Lisa Ricciardi Title: President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing